REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 72 filers reported holding REPARE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,124,477 | -99.9% | 144,424 | +18.0% | 0.00% | 0.0% |
| Q3 2022 | $1,484,032,000 | -24.6% | 122,344 | -13.1% | 0.00% | 0.0% |
| Q2 2022 | $1,969,415,000 | -5.3% | 140,773 | -3.6% | 0.00% | 0.0% |
| Q1 2022 | $2,078,897,000 | -37.5% | 145,990 | -7.4% | 0.00% | 0.0% |
| Q4 2021 | $3,323,869,000 | -21.1% | 157,604 | -1.8% | 0.00% | -50.0% |
| Q3 2021 | $4,211,494,000 | -18.6% | 160,499 | -3.3% | 0.00% | 0.0% |
| Q2 2021 | $5,176,473,000 | -7.2% | 166,019 | -8.6% | 0.00% | 0.0% |
| Q1 2021 | $5,576,096,000 | -8.0% | 181,691 | +2.8% | 0.00% | -33.3% |
| Q4 2020 | $6,062,285,000 | +5.2% | 176,743 | -5.6% | 0.00% | 0.0% |
| Q3 2020 | $5,762,267,000 | +0.6% | 187,269 | +1.4% | 0.00% | -25.0% |
| Q2 2020 | $5,730,449,000 | – | 184,734 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $32,989,176 | 13.80% |
| CHI Advisors LLC | 2,800,126 | $41,189,854 | 10.97% |
| MPM BioImpact LLC | 1,639,849 | $24,122,179 | 6.26% |
| BVF INC/IL | 8,291,988 | $121,975,143 | 5.15% |
| Deep Track Capital, LP | 2,727,606 | $40,123,084 | 1.68% |
| Redmile Group, LLC | 2,684,396 | $39,487,465 | 1.62% |
| HighVista Strategies LLC | 164,890 | $2,425,532 | 1.44% |
| Orbimed Advisors | 3,322,488 | $48,873,798 | 0.94% |
| Artal Group S.A. | 700,000 | $10,297 | 0.58% |
| HARBOR CAPITAL ADVISORS, INC. | 34,572 | $508,554 | 0.49% |